DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Scott Weiner will speak about Pappas Ventures’ perspective on the Medtech market at the IN3 West: Investment in Innovation Conference in Las Vegas, NV.
News | 02. 22. 2011
